KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

Shares U.S. Medical Devices ETF offers targeted exposure to U.S. medical device leaders, benefiting from demographic shifts ...

New and Unprecedented Survival, Respiratory, and Biomarker Data Prove that NurOwn Helps People with ALS Live Longer and Live ...

The signers acknowledged that leaders of their professions had previously condemned a street protest against lockdown ...

In a significant development, the Maharashtra Food and Drug Administration (FDA) has directed chemists across the state to ...

KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.

Wave Life Sciences could offer significant upside if obesity candidate WVE-007 delivers strong human data. Check out the ...

WASHINGTON — The steady erosion of experienced staff at the Food and Drug Administration is slowly compromising the agency’s ...

Those questions, experts say, are based on the Trump administration’s hawkish approach to China generally, as well as on a ...

The system is used with CT scans to develop a 3D surgical plan to help ensure an accurate hip replacement surgery ...

HHS Secretary Robert F. Kennedy Jr. was on The Tucker Carlson Show last week. It got me to thinking: What's next in RFK Jr.'s ...

The global medical foods market is on a breath taking ascent, underpinned by rising chronic disease rates, growing geriatric ...